Accomplishments

Houlihan Lokey’s Recent Accomplishments in Retail Healthcare and Physician Practice Management 
           

Retail healthcare and physician practice management (PPM) are significant components of Houlihan Lokey’s healthcare franchise.

Over the last twelve months, we have closed 12 M&A and capital markets transactions across the sector including several notable deals in urgent care, dental, vision, vet, dermatology, anesthesiology, orthopedics, and other physician services.

Houlihan Lokey is among the most active advisors within retail healthcare and PPM having closed 32 transactions in the space since 2016.

For more information on our services and sector insights please contact a member of the Houlihan Lokey healthcare team or visit HL.com.

2018 Selected Transactions

Leading M&A focused urgent care platform

Largest dermatology services platform in NY and fourth largest in the U.S. Leading de novo focused urgent care provider in Florida

One of the fastest growing DSOs, with 80+ offices

Leading M&A focused veterinary practice management platform Leading dermatology services platform with more than 30 locations in Florida

Largest ophthalmology platform in the Midwest

Leading urgent care provider in Long Island Largest provider of anesthesia and pain management services in Michigan

 

Other Notable Transactions

Largest orthopaedic platform in North Central Florida

Leading ophthalmology platform in the New York Tri-State area Largest orthodontic DSO with more than 90 affiliated practices in 11 states

Second largest independent urgent care provider

Largest pain management platform in the U.S. with 69 clinics Leading provider of outpatient rehab services in the mid-Atlantic

One of the largest specialty DSOs, with 70+ offices

Leading rural-focused urgent care provider in the U.S. Leading dermatology platform comprised of over 40 clinics

Tombstones included herein represent transactions closed from 2016 forward.


Retail Healthcare and Physician Practice Management Contacts

Head of the Healthcare Group
Mark Francis Managing Director MFrancis@HL.com 214.220.8484

Senior Officers
Michael Pisani Managing Director MPisani@HL.com 214.665.8611
Karan Garg Managing Director KGarg@HL.com 312.456.4758
Matthew Wedge Senior Vice President MWedge@HL.com 214.220.8489
Brad Hildebrand Vice President BHildebrand@HL.com 312.462.6430
Eric Weldzius Vice President EWeldzius@HL.com 312.462.6487

* * * * * * *

Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia‑Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. Houlihan Lokey is ranked as the No. 1 M&A advisor for all U.S. transactions, the No. 1 global restructuring advisor, and the No. 1 global M&A fairness opinion advisor over the past 20 years, according to Thomson Reuters.

Follow us on LinkedIn Follow us

HL.com
Houlihan Lokey is a trade name for Houlihan Lokey, Inc., and its subsidiaries and affiliates, which include those in (i) the United States: Houlihan Lokey Capital, Inc., an SEC-registered broker-dealer and member of FINRA (www.finra.org) and SIPC (www.sipc.org) (investment banking services); Houlihan Lokey Financial Advisors, Inc. (financial advisory services); Houlihan Lokey Consulting, Inc. (strategic consulting services); HL Finance, LLC (syndicated leveraged finance platform); and Houlihan Lokey Real Estate Group, Inc. (real estate advisory services); (ii) Europe: Houlihan Lokey EMEA, LLP and Houlihan Lokey (Corporate Finance) Limited, authorized and regulated by the U.K. Financial Conduct Authority; Houlihan Lokey GmbH; Houlihan Lokey (Netherlands) B.V.; and Houlihan Lokey (España), S.A.; (iii) the United Arab Emirates, Dubai International Financial Centre (Dubai): Houlihan Lokey (MEA Financial Advisory) Limited, regulated by the Dubai Financial Services Authority for the provision of advising on financial products, arranging deals in investments, and arranging credit and advising on credit to professional clients only; (iv) Singapore: Houlihan Lokey (Singapore) Private Limited, an “exempt corporate finance adviser” able to provide exempt corporate finance advisory services to accredited investors only; (v) Hong Kong SAR: Houlihan Lokey (China) Limited, licensed in Hong Kong by the Securities and Futures Commission to conduct Type 1, 4, and 6 regulated activities to professional investors only; (vi) China: Houlihan Lokey Howard & Zukin Investment Consulting (Beijing) Co., Limited (financial advisory services); (vii) Japan: Houlihan Lokey K.K. (financial advisory services); and (viii) Australia: Houlihan Lokey (Australia) Pty Limited (ABN 74 601 825 227), a company incorporated in Australia and licensed by the Australian Securities and Investments Commission (AFSL number 474953) in respect of financial services provided to wholesale clients only. In the European Economic Area (EEA), Dubai, Singapore, Hong Kong, and Australia, this communication is directed to intended recipients, including actual or potential professional clients (EEA and Dubai), accredited investors (Singapore), professional investors (Hong Kong), and wholesale clients (Australia), respectively. Other persons, such as retail clients, are NOT the intended recipients of our communications or services and should not act upon this communication. This email is an advertisement from Houlihan Lokey. To opt-out from receiving marketing communications from Houlihan Lokey and to manage your preferences in relation to the communications that Houlihan Lokey sends you, click here. Written inquiries can be sent to 10250 Constellation Blvd., 5th Fl., Los Angeles, CA 90067, or you may reach us via our contact page.


CONTACT US TERMS OF USE PRIVACY